Telix Pharmaceuticals Lim... (TLX)
NASDAQ: TLX
· Real-Time Price · USD
11.85
0.31 (2.69%)
At close: Aug 18, 2025, 3:59 PM
12.27
3.54%
After-hours: Aug 18, 2025, 06:56 PM EDT
2.69% (1D)
| Bid | 11.9 |
| Market Cap | 4.01B |
| Revenue (ttm) | 783.21M |
| Net Income (ttm) | 49.92M |
| EPS (ttm) | 0.09 |
| PE Ratio (ttm) | 131.67 |
| Forward PE | 19.95 |
| Analyst | Buy |
| Ask | 12.49 |
| Volume | 199,996 |
| Avg. Volume (20D) | 52,656 |
| Open | 11.69 |
| Previous Close | 11.54 |
| Day's Range | 11.61 - 12.07 |
| 52-Week Range | 10.70 - 30.36 |
| Beta | 2.43 |
Analyst Forecast
According to 0 analyst ratings, the average rating for TLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+12%
Telix Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
6 months ago
+1.07%
Telix Pharmaceuticals shares are trading higher after the company announced it will buy the therapeutic pipeline, technology platform, and research facility from ImaginAb.
2 weeks ago · seekingalpha.com
Telix Pharmaceuticals: Assessing The Market's Pullback On SEC InquiryTLX boasts a diverse pipeline and strong sales growth, especially with Illuccix and Gozellix, supporting my continued confidence in their theranostics approach. Financials remain robust, with year-ove...
